TRERF1 and glomerulosclerosis: RAPA increased the survival rate of MRL/lpr mice (Fig. 1B) and alleviated symptoms of LN, including 24-h urinary protein, serum anti-ds-DNA antibody levels, and glomerular sclerosis (Fig. 1C–E).